MedTrace Logo

A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

NCT07254208 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2026-04-22

No results posted yet for this study

Summary

Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.

Conditions

  • Chronic HBV Infection

Interventions

BIOLOGICAL

PBGENE-HBV

PBGENE-HBV is the investigational product administered in the parent study. This LTFU study is non-interventional; no investigational product given.

Sponsors & Collaborators

  • Precision BioSciences, Inc.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-25
Primary Completion
2040-01-31
Completion
2040-06-30
FDA Drug
Yes

Countries

  • United States
  • Hong Kong
  • Moldova
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07254208 on ClinicalTrials.gov